Cancer immunology: the search for specificity
National Cancer Institute Monograph
|January 1, 1982
Summary
Researchers are investigating tumor-specific antigens for cancer immunology. While some Class 1 antigens show promise as tumor-specific markers, further study is needed to understand their role in cancer control.
Area of Science:
- Cancer Immunology
- Tumor Antigen Research
Background:
- The focus in cancer immunology has shifted from immunosurveillance theories to identifying tumor-specific antigens.
- Despite extensive efforts, the general existence of tumor-specific antigens across cancers remains unproven.
- Serological analysis of mouse leukemia/sarcoma and human melanoma has begun to classify tumor surface antigens.
Purpose of the Study:
- To evaluate the significance of Class 1 antigens as potential tumor-specific markers.
- To explore the genetic origin and properties of thymus leukemia (TL) antigens in relation to tumor antigens.
- To determine the necessity of detailed surface antigen knowledge for assessing immunological cancer control.
Main Methods:
- Serological analysis of mouse leukemia, mouse sarcoma, and human malignant melanoma.
- Definition and characterization of Class 1 antigens on tumor cells.
- Investigation of thymus leukemia (TL) antigen expression and genetic basis.
Main Results:
- Certain Class 1 antigens exhibit absolute restriction to individual tumors, making them prime candidates for tumor specificity.
- Thymus leukemia (TL) antigens in mice display characteristics of both differentiation and tumor-specific antigens.
- Leukemias in mice lacking TL antigens can express them, indicating universal genetic information for TL.
Conclusions:
- Class 1 antigens are the most promising candidates for tumor-specific antigens identified to date.
- TL antigens provide insights into the complex genetic origins of tumor antigens.
- A deeper understanding of tumor cell surface antigens is crucial for developing effective immunological cancer control strategies.
Related Concept Videos
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:20Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...